Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News


September 30, 2013
Antifungal Drug Shows Promise Fighting HIV in the Lab
The topical antifungal agent Ciclopirox clears HIV by promoting infected cells to effectively commit suicide and also prevents viral rebound after termination.
September 27, 2013
Gene Therapy Shows Promise in Controlling HIV
Scientists have proved that it is possible to engineer immune cells to control HIV for a sustained period of time without the need for ongoing antiretrovirals.
September 26, 2013
Significant Drop in Global New HIV Cases and AIDS Deaths
The global effort to combat HIV has achieved dramatic success during the past decade, with significant decreases in new HIV cases and AIDS-related deaths. 
September 25, 2013
Government Shutdown May Slow FDA Drug Approvals
The looming threat of a government shutdown on October 1 may spell potential delays in Food and Drug Administration (FDA) approvals of new drugs.
September 24, 2013
Costs Kept Low in Obamacare Plans Through Less Choice
New Obamacare health plans are able to keep premiums lower by tightening networks of physicians and hospitals and by paying less for medical care.
September 23, 2013
New Tenofovir Has Lower Dose, Is Kinder to Kidneys and Bones
A new formulation of the widely used HIV antiretroviral tenofovir is potent at a lower dose and works as well as the current version of the drug.
Waistlines Tied to Liver Stiffness in Women With Hep C
Women living with hepatitis C are more inclined to have liver stiffness if they have larger waistlines.
September 20, 2013
Sexually ‘Versatile’ Gay Men Likely Fueling HIV Spread
The fact that gay men who practice unprotected anal intercourse are largely versatile in their anal sex roles likely fuels HIV’s rapid spread among the population.
September 19, 2013
Costs Spike for 2nd- and 3rd-Line ARVs and Late Treatment
The cost to treat HIV-positive people with second- and third-line antiretrovirals jumps by a respective 24 and 41 percent compared with first-line therapies.
September 18, 2013
CD4 Cell’s Main Coreceptor Is Mapped in High Resolution
For the first time, researchers have documented the microscopic structure of the CCR5 coreceptor, which HIV binds to in order to begin its entry into CD4 cells.
September 17, 2013
New Vaccine Clears AIDS-Causing Virus in Monkeys
A new vaccine appears to have completely cured monkeys of simian immunodeficiency virus, a primate cousin of HIV, raising hopes for the field of research.
September 16, 2013
Women Spontaneously Clear Hep C Better Than Men
Spontaneous clearance of acute hepatitis C is more likely to occur among women, those with the IL28B virus genotype and those who have genotype 1. 
PrEP Adherence Curbs HIV Transmission in Straight Couples
Close adherence to a pre-exposure prophylaxis (PrEP) regimen spells success in preventing HIV transmission within heterosexual couples in which only one has HIV.
September 13, 2013
Early, Short Course of HIV Meds for Infants Better Than a Delay
For HIV-positive newborns, immediate treatment followed by a treatment interruption provides better results than waiting to begin therapy until HIV progresses.
September 12, 2013
Improvements Needed in Addressing Global Pediatric HIV
The global stakeholders need to improve their tactics in both diagnosing and treating HIV among children, according to an editorial published in PLOS Medicine. 
September 11, 2013
Partner Violence May Reduce Female-Initiated HIV Prevention
Women who suffer violence at the hands of their male partners are less inclined to use condoms or diaphragms.
September 10, 2013
Circumcision Program in South African Town Reduces HIV Rates
An effort to widely circumcise men in Orange Farm, South Africa, has proved popular with local men and has succeeded in lowering HIV prevalence by a fifth.
September 09, 2013
Even Very Low Viral Loads Can Lead to Treatment Failure
HIV-positive people on treatment who have a persistently detectable viral load, even a very low one, are at an increased risk for treatment failure.
HIV/Hep B Coinfection Responds Very Well to Viread
The HIV antiretroviral Viread (tenofovir) is highly effective in combating both HIV and hepatitis B among those coinfected with both viruses.
September 06, 2013
PrEP Did Not Increase Sexual Risks in Study of Gay Men
Pre-exposure prophylaxis did not cause gay men to have riskier sex in a recent trial. However, the study does not necessarily reflect a real-world setting.
September 05, 2013
HIV Vaccine Based on Whole Virus Completes Phase I Trial
An HIV vaccine based on a genetically modified killed whole virus is the first of its kind to succeed in a Phase I clinical trial, proving safe, well tolerated and immunogenic.
September 04, 2013
Insufficient HIV Testing May Make Gay Relationships Risky
One in five gay men dating an HIV-negative partner have not been tested for HIV during their relationship.
September 03, 2013
HIV Death Rate Drops 21% Worldwide, But Not Evenly
The global death rate from HIV dropped 21 percent in five years, although vast disparities exist between different regions in the world.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ



Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    dhsd777
    san diego
    California


    newlife202
    JOLIET
    Illinois


    TaintedloveDC
    Washington
    DC


    kmfdm221
    Arcata
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Can social media help stop HIV stigma?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.